Company Description
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, ...
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Valuation
P/E Current
81.63
P/E Ratio (with extraordinary items)
74.76
P/E Ratio (without extraordinary items)
72.64
Price to Sales Ratio
15.44
Price to Book Ratio
8.41
Price to Cash Flow Ratio
64.43
Enterprise Value to EBITDA
52.17
Enterprise Value to Sales
15.12
Total Debt to Enterprise Value
0.00
Efficiency
Revenue/Employee
513,383.00
Income Per Employee
109,101.00
Receivables Turnover
6.33
Total Asset Turnover
0.47
Liquidity
Current Ratio
4.40
Quick Ratio
3.77
Cash Ratio
2.90
Profitability
Gross Margin
67.30
Operating Margin
25.35
Pretax Margin
25.82
Net Margin
21.25
Return on Assets
9.97
Return on Equity
11.53
Return on Total Capital
13.57
Return on Invested Capital
11.46
Capital Structure
Total Debt to Total Equity
0.85
Total Debt to Total Capital
0.84
Total Debt to Total Assets
0.72
Long-Term Debt to Equity
0.63
Long-Term Debt to Total Capital
0.63
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. David J. Rosa | 52 | 1996 | Chief Business Officer & Executive Vice President |
Dr. Gary S. Guthart | 54 | 1996 | President, Chief Executive Officer & Director |
Mr. Robert Desantis | 55 | 2013 | EVP, GM-Instruments, Accessories & Endoscope |
Mr. Jamie E. Samath | 48 | 2013 | Senior Vice President-Finance |
Dr. Myriam J. Curet | 64 | 2005 | Chief Medical Officer & Executive Vice President |
Insider Actions
08/07/2023 |
Alan J. Levy Director |
465 | Disposition at $310 per share. | 144,150 |
08/07/2023 |
Alan J. Levy Director |
1,535 | Disposition at $310 per share. | 475,850 |
08/07/2023 |
Alan J. Levy Director |
465 | Derivative/Non-derivative trans. at $71.32 per share. | 33,163 |
08/07/2023 |
Alan J. Levy Director |
1,535 | Derivative/Non-derivative trans. at $90.49 per share. | 138,902 |
07/31/2023 |
Gary S. Guthart CEO; Director |
2,480 | Disposition at $325.89 per share. | 808,207 |
07/31/2023 |
Gary S. Guthart CEO; Director |
2,480 | Disposition at $325.89 per share. | 808,207 |
07/28/2023 |
Gary S. Guthart CEO; Director |
16,000 | Gift at $0 per share. | 0 |
07/28/2023 |
Gary S. Guthart CEO; Director |
50,314 | Disposition at $326.76 per share. | 16,440,602 |
07/28/2023 |
Gary S. Guthart CEO; Director |
67,500 | Derivative/Non-derivative trans. at $42.64 per share. | 2,878,200 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
564 | Disposition at $322.76 per share. | 182,036 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
270 | Disposition at $322.76 per share. | 87,145 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
270 | Disposition at $322.76 per share. | 87,145 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
273 | Disposition at $322.76 per share. | 88,113 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
594 | Disposition at $322.76 per share. | 191,719 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
564 | Disposition at $325 per share. | 183,300 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
564 | Derivative/Non-derivative trans. at $208.9 per share. | 117,819 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
270 | Derivative/Non-derivative trans. at $177.99 per share. | 48,057 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
270 | Derivative/Non-derivative trans. at $179.7 per share. | 48,519 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
273 | Derivative/Non-derivative trans. at $242.34 per share. | 66,158 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
594 | Derivative/Non-derivative trans. at $245.6 per share. | 145,886 |
07/25/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
564 | Derivative/Non-derivative trans. at $290.33 per share. | 163,746 |
06/14/2023 |
Marshall L. Mohr Executive VP Global Business S |
11,250 | Disposition at $325 per share. | 3,656,250 |
06/14/2023 |
Craig H. Barratt Director |
1,567 | Disposition at $322.78 per share. | 505,796 |
06/14/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
2,443 | Disposition at $325 per share. | 793,975 |
06/14/2023 |
Marshall L. Mohr Executive VP Global Business S |
11,250 | Derivative/Non-derivative trans. at $59.46 per share. | 668,925 |
06/14/2023 |
Craig H. Barratt Director |
1,567 | Derivative/Non-derivative trans. at $41.26 per share. | 64,654 |
06/14/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
2,443 | Derivative/Non-derivative trans. at $290.33 per share. | 709,276 |
05/11/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
169 | Derivative/Non-derivative trans. at $303.47 per share. | 51,286 |
05/11/2023 |
Robert Desantis EVP & Chief Strategy & Corp Op |
363 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/02/2023 |
Myriam J. Curet EVP & Chief Medical Officer |
138 | Gift at $0 per share. | 0 |
05/01/2023 |
Craig H. Barratt Director |
2,000 | Disposition at $306 per share. | 612,000 |
05/01/2023 |
Craig H. Barratt Director |
2,000 | Derivative/Non-derivative trans. at $41.26 per share. | 82,520 |
04/28/2023 |
Mark J. Rubash Director |
523 | Disposition at $300 per share. | 156,900 |
04/28/2023 |
Mark J. Rubash Director |
1,391 | Disposition at $300 per share. | 417,300 |
04/28/2023 |
Mark J. Rubash Director |
895 | Disposition at $300 per share. | 268,500 |
04/28/2023 |
Mark J. Rubash Director |
707 | Disposition at $300 per share. | 212,100 |
04/28/2023 |
Mark J. Rubash Director |
688 | Disposition at $300 per share. | 206,400 |
04/28/2023 |
Mark J. Rubash Director |
1,671 | Disposition at $300 per share. | 501,300 |
04/28/2023 |
Mark J. Rubash Director |
1,448 | Disposition at $300 per share. | 434,400 |
04/28/2023 |
Mark J. Rubash Director |
523 | Derivative/Non-derivative trans. at $71.32 per share. | 37,300 |
04/28/2023 |
Mark J. Rubash Director |
1,391 | Derivative/Non-derivative trans. at $90.49 per share. | 125,871 |
04/28/2023 |
Mark J. Rubash Director |
895 | Derivative/Non-derivative trans. at $154.24 per share. | 138,044 |
04/28/2023 |
Mark J. Rubash Director |
707 | Derivative/Non-derivative trans. at $172.59 per share. | 122,021 |
04/28/2023 |
Mark J. Rubash Director |
688 | Derivative/Non-derivative trans. at $171.07 per share. | 117,696 |
04/28/2023 |
Mark J. Rubash Director |
1,671 | Derivative/Non-derivative trans. at $286.55 per share. | 478,825 |
04/28/2023 |
Mark J. Rubash Director |
1,448 | Derivative/Non-derivative trans. at $243.26 per share. | 352,240 |
04/27/2023 |
Craig H. Barratt Director |
655 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Alan J. Levy Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Mark J. Rubash Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Amal M. Johnson Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Jami K. Dover Nachtsheim Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Keith R. Leonard Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Donald R. Kania Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Joseph C. Beery Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Amy L. Ladd Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/27/2023 |
Monica P. Reed Director |
482 | Derivative/Non-derivative trans. at $0 per share. | 0 |
MarketWatch News on ISRG
-
Intuitive Surgical Inc. stock falls Tuesday, underperforms market
- MarketWatch Automation
-
Stryker Corp. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Stryker Corp. stock rises Monday, outperforms market
- MarketWatch Automation
-
Intuitive Surgical Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Intuitive Surgical Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Stryker Corp. stock outperforms market despite losses on the day
- MarketWatch Automation
-
Stryker Corp. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Intuitive Surgical Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Intuitive Surgical Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Stryker Corp. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Intuitive Surgical Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Stryker Corp. stock falls Tuesday, underperforms market
- MarketWatch Automation
-
Intuitive Surgical Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Stryker Corp. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
11 Beaten-Up Growth Stocks That Look Like Buys, Says Citi
- Barron's Online
-
Intuitive Surgical Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Stryker Corp. stock outperforms market on strong trading day
- MarketWatch Automation
-
Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
- Loading more headlines...
Other News on ISRG
-
The Ozempic Craze Could Put These Companies on a Crash Diet
- The Wall Street Journal Interactive Edition
-
Those Hip Surgeries Are Now Mostly Priced Into Insurers’ Stocks
- The Wall Street Journal Interactive Edition
-
The Return-to-Normal Healthcare Trade Picks Up Pace
- The Wall Street Journal Interactive Edition
-
- Edgar Online - (EDG = 10Q, 10K)
-
Steven Cohen Takes Stake in Inari Medical
- GuruFocus.com
-
Top 5 4th Quarter Trades of WISCONSIN CAPITAL MANAGEMENT LLC
- GuruFocus.com
-
DF DENT & CO INC Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
AMERIPRISE FINANCIAL INC Buys 4, Sells 1 in 4th Quarter
- GuruFocus.com
-
PFM Health Sciences, LP Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
Moderna and Cirrus Logic Are Balance Sheet Powerhouses
- GuruFocus.com
-
Top 5 4th Quarter Trades of CIM, LLC
- GuruFocus.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Top 5 4th Quarter Trades of ALBION FINANCIAL GROUP /UT
- GuruFocus.com
-
Top 5 4th Quarter Trades of EXCHANGE TRADED CONCEPTS, LLC
- GuruFocus.com
-
Top 5 4th Quarter Trades of NORTHSTAR ASSET MANAGEMENT LLC
- GuruFocus.com
-
Top 5 4th Quarter Trades of BNC WEALTH MANAGEMENT, LLC
- GuruFocus.com
-
MCDANIEL TERRY & CO Goes on Buying Spree in 4th Quarter
- GuruFocus.com
-
Intuitive Surgical: A High-Quality, High-Growth Leader
- GuruFocus.com
- Loading more headlines...